Sale!

Design And Development of A Starch-Based Multifunctional Excipient (Stargelasil) For Tablet Formulation.

3,000.00

If you are interested in getting this project material “Design and Development of a Starch-Based Multifunctional Excipient (Stargelasil) for Tablet Formulation”, click on the DOWNLOAD BUTTON to make payment and the file will be delivered to your email immediately after confirmation.

Description

Download Design and Development of a Starch-Based Multifunctional Excipient (Stargelasil) for Tablet Formulation. Pharmacognosy students who are writing their projects can get this material to aid their research work.

Abstract

The concept of co-processing as a particle engineering technique has been used as a tool to improve the functionality of many existing excipients. This study was designed to improve the functionality of cassava starch as excipient for direct compression by coprocessing with gelatin and colloidal silicon dioxide.

The Design of Experiment (DoE) approach was employed to optimize the percentage ratios of the primary excipients for the co-processed excipient.

Fourteen experimental formulations containing varying proportions of the primary excipients were prepared by the method of co-fusion and twelve tablets each weighing 400 mg each were produced for each formulation using the Hydraulic Carver Press.

The compressed tablets were kept for 24 h in the desiccator and evaluated for tensile strength and disintegration time. The data obtained from the tablets were suitably analysed using the Design Expert software and fitted to a special quartic model that correlated the effect of varying the proportions of the excipients in the different formulations on tablet properties.

Introduction

The European Pharmacopoeia (2002) defines tablets as solid preparations each containing a single dose of one or more active substances and usually obtained by compressing uniform volumes of particles.

Tablets are intended for oral administration. Some are swallowed whole, some after being chewed, some are dissolved or dispersed in water before being administered and some are retained in the mouth where the active substance is liberated.

Despite the long and continuing history of the development of new technologies for administration of drugs, the tablet form remains the most commonly used dosage form (European Pharmacopoeia, 2002).

How to Download this Project Material

First, note that we are one of the best and most reliable online platforms because we don’t retain any of your personal information or data as regards making payments online.

PRICE: ₦3,500 ₦3,000  (Three Thousand Naira Only)

Make a bank deposit or mobile transfer of ₦2,000 only to the account given below;


Bank Name: UBA
Account Number: 1022564031
Account Name: TMLT PRO SERVICES


After making the payment, CLICK HERE to send the following on WhatsApp;

  • Depositor’s Name or Screenshot of Payment
  • Name of the Past Question
  • Active Email Address

or Call Us On +2348082284439

Once your details have been received and your payment confirmed by us, you will receive the past question in your email or WhatsApp within 5 Minutes.

Guarantee of Getting the Material 

We understand that due to the high rate of fraud, many people are afraid of making purchases online but be rest assured that PastExamQuestions will deliver your material after payment.

Once your details have been received and your payment confirmed by us, you will receive the past question in your email or WhatsApp.

Give us Feedback

Have we been able to satisfy you? How well do you think the material will be helpful after having gone through it? Does the price worth the material? Let’s hear from you!

We recommend that our customers give feedback at the end of every transaction to enable us to serve better. You can do this by clicking the review button on this page.

Where is the review button? >> Just scroll up to where you see reviews

Reviews

There are no reviews yet.

Be the first to review “Design And Development of A Starch-Based Multifunctional Excipient (Stargelasil) For Tablet Formulation.”

Your email address will not be published. Required fields are marked *